


Ask a doctor about a prescription for IBUPROFEN ABDRUG 600 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Ibuprofen ABDrug 600 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine.
Contents of the pack:
Ibuprofen belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
This medicine is indicated for the treatment of fever, pain of mild or moderate intensity in processes such as dental pain, post-surgical pain, headache including migraine, symptomatic relief of pain, fever, and inflammation that accompanies processes such as pharyngitis, tonsillitis, and otitis, among others, treatment of rheumatoid arthritis (inflammation of the joints, including usually those of the hands and feet, leading to swelling and pain), psoriatic arthritis (skin disease), gout (uric acid deposits in the joints that cause pain), osteoarthritis (chronic disorder that causes cartilage damage), ankylosing spondylitis (inflammation that affects the joints of the spine), non-rheumatic inflammation or other types of inflammatory injuries of traumatic or sports origin, and primary dysmenorrhea (painful menstruation).
Do not take Ibuprofen ABDrug:
Warnings and precautions:
Tell your doctor:
This risk is higher when high doses and prolonged treatments are used, in patients with a history of peptic ulcer and in the elderly. In these cases, your doctor will consider the possibility of associating a stomach protective medication.
Skin reactions
Severe skin reactions have been reported with Ibuprofen ABDrug treatment. Stop taking Ibuprofeno ABDrug and consult your doctor immediately if you experience any skin rash, mucous membrane lesions, blisters, or other signs of allergy, as these may be the first signs of a severe skin reaction. See section 4.
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Discontinue ibuprofen treatment and seek medical attention immediately if you notice any symptoms related to these severe skin reactions described in section 4.
Cardiovascular precautions
Anti-inflammatory/analgesic medications like Ibuprofeno ABDrug may be associated with a small increased risk of suffering a heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking Ibuprofeno ABDrug if:
Additionally, these types of medications can cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
Ibuprofen has been associated with signs of allergic reaction to this medication, such as respiratory problems, swelling of the face and neck area (angioedema), and chest pain. Stop using ibuprofen immediately and contact your doctor or emergency medical services if you observe any of these signs.
Infections
Ibuprofen may mask the signs of an infection, such as fever and pain. Consequently, this medication may delay appropriate treatment of the infection, which can increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Precautions during pregnancy and in women of childbearing age
Because the administration of medications like Ibuprofeno ABDrug has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy unless it is strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
In the third trimester, the administration of this medication is contraindicated.
For women of childbearing age, it should be taken into account that medications like Ibuprofeno ABDrug have been associated with a decrease in fertility.
Using Ibuprofeno ABDrug with other medications
Tell your doctor or pharmacist if you are using or have recently used any other medication, including those purchased without a prescription.
Ibuprofeno ABDrug may affect or be affected by other medications. For example:
Other medications may also affect or be affected by treatment with Ibuprofeno ABDrug. Therefore, you should always consult your doctor or pharmacist before using Ibuprofeno ABDrug with other medications.
Taking ibuprofen may affect the following laboratory tests:
Tell your doctor if you are going to undergo a clinical analysis and are taking or have recently taken ibuprofen.
Taking Ibuprofeno ABDrug with food and drinks:
You can take it alone or with food. In general, it is recommended to take it before meals or with milk to reduce the possibility of stomach upset.
Pregnancy and breastfeeding:
Consult your doctor or pharmacist before using any medication.
Do not take ibuprofen during pregnancy, especially during the third trimester. Although only small amounts of the medication pass into breast milk, it is recommended not to take ibuprofen for prolonged periods during breastfeeding.
Therefore, if you become pregnant or are breastfeeding, consult your doctor.
Driving and using machines:
If you experience dizziness, vertigo, vision changes, or other symptoms while taking this medication, do not drive or use hazardous machinery. If you only take one dose of ibuprofen or for a short period, it is not necessary to take special precautions.
Important information about some of the components of Ibuprofeno ABDrug:
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the administration instructions of Ibuprofeno ABDrug indicated by your doctor. Consult your doctor or pharmacist if you have doubts.
Your doctor will indicate the duration of treatment with this medication. Do not stop treatment before, as the expected results will not be obtained. Similarly, do not use Ibuprofeno ABDrug for longer than indicated by your doctor.
The effective lowest dose should be used during the shortest necessary time to relieve symptoms. If you have an infection, consult a doctor without delay if the symptoms (such as fever and pain) persist or worsen (see section 2). This medication is administered orally.
Adults
In adults and young people from 12 to 18 years, take one tablet (600 mg) every 6 to 8 hours, depending on the intensity of the condition and response to treatment.
In some processes, higher doses may be required, but in any case, it is recommended not to exceed the maximum daily dose of 2400 mg in adults and 1600 mg in young people from 12 to 18 years.
Children
Do not administer Ibuprofeno ABDrug to children under 12 years without consulting a doctor.
Elderly
If you are over 60 years old, your doctor may prescribe a lower dose than usual. If so, the dose can only be increased once your doctor has checked that you tolerate the medication well.
Patient with kidney and/or liver disease
If you have kidney and/or liver disease, your doctor may prescribe a lower dose than usual. If so, take the exact dose prescribed by your doctor.
If you think the effect of Ibuprofeno ABDrug is too strong or too weak, tell your doctor or pharmacist.
If you take more Ibuprofeno ABDrug than you should
If you have taken more Ibuprofeno ABDrug than you should, or if a child has accidentally ingested the medication, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested, to inform yourself of the risk and ask for advice on the measures to be taken. It is recommended to take the package and the package leaflet of the medication to the healthcare professional. If a severe overdose has occurred, the doctor will take the necessary measures.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain blood), gastrointestinal bleeding (see also section 4), diarrhea, headache, ringing in the ears, confusion, and involuntary eye movement.
Agitation, drowsiness, disorientation, or coma may also occur. Occasionally, patients develop seizures. At high doses, somnolence, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, feeling of cold in the body, and respiratory problems have been reported. Additionally, the prothrombin time/INR may be prolonged due to interaction with circulating coagulation factors. Acute kidney failure and liver damage may occur. Exacerbation of asthma in asthmatics is also possible. Furthermore, hypotension and decreased respiration may occur.
If you forget to take Ibuprofeno ABDrug
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time of the next dose is near, skip the forgotten dose and take the next dose at the usual time.
Like all medications, Ibuprofeno ABDrug may have adverse effects, although not all people suffer from them.
The adverse effects of medications like Ibuprofeno ABDrug are more common in people over 65 years old.
The incidence of adverse effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
The following adverse effects have been observed:
Gastrointestinal:
The most frequent adverse effects are gastrointestinal: peptic ulcers, digestive bleeding, perforations (in some cases fatal), especially in the elderly. Nausea, vomiting, diarrhea, flatulence, constipation, heartburn, abdominal pain, blood in stools, oral thrush, worsening of ulcerative colitis, and Crohn's disease have also been observed. Gastritis has been observed less frequently.
Other adverse effects are:
Uncommon(at least 1 in 1,000 patients): inflammation of the oral mucosa with ulcer formation.
Rare(at least 1 in 10,000 patients): esophageal inflammation, esophageal narrowing (esophageal stenosis), exacerbation of intestinal diverticulitis, hemorrhagic colitis (gastroenteritis with bloody diarrhea).
Very rare: pancreatitis.
Cardiovascular:
Medications like Ibuprofeno ABDrug 600 mg tablets may be associated with a moderate increased risk of suffering a heart attack ("myocardial infarction") or stroke. Edema (fluid retention), arterial hypertension, and heart failure have also been observed in association with treatments with medications of the Ibuprofeno ABDrug type.
Chest pain, which can be a sign of a potentially severe allergic reaction called Kounis syndrome.
Dermatological:
Medications like Ibuprofeno ABDrug may be associated, in very rare cases, with severe blistering reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis.
Other adverse effects are:
Common(at least 1 in 100 patients): skin rash.
Uncommon(at least 1 in 1,000 patients): skin redness, itching or skin swelling, purpura (purple spots on the skin).
Very rare(less than 1 in 10,000 patients): hair loss, erythema multiforme (skin lesion), skin reactions due to light influence, inflammation of the skin blood vessels. Frequency not known: The skin becomes sensitive to light. Generalized red scaly rash, with bumps under the skin and blisters, mainly on skin folds, trunk, and upper limbs, accompanied by fever at the start of treatment (acute generalized exanthematous pustulosis). Stop taking Ibuprofeno ABDrug if you experience these symptoms and seek medical attention immediately. See also section 2.
Drug reaction with eosinophilia and systemic symptoms: A severe skin reaction known as DRESS syndrome can occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils (a type of white blood cell).
Immune system:
Uncommon(at least 1 in 1,000 patients): transient edema in skin, mucous membranes, or sometimes in viscera (angioedema), nasal mucosa inflammation, bronchospasm.
Rare(at least 1 in 10,000 patients): severe allergic reactions (anaphylactic shock).
Very rare(less than 1 in 10,000 patients): joint pain and fever (lupus erythematosus).
Central nervous system:
Common(at least 1 in 100 patients): fatigue or drowsiness, headache, and dizziness or feeling of instability.
Rare(at least 1 in 10,000 patients): tingling sensation.
Very rare(less than 1 in 10,000 patients): aseptic meningitis. In most cases where aseptic meningitis has been reported with ibuprofen, the patient had some form of autoimmune disease (such as systemic lupus erythematosus or other collagen diseases), which was a risk factor.
Psychiatric:
Uncommon(at least 1 in 1,000 patients): insomnia, anxiety, restlessness.
Rare(at least 1 in 10,000 patients): paresthesia, disorientation or confusion, agitation, irritability, depression, psychotic reaction.
Auditory:
Common(at least 1 in 100 patients): vertigo.
Uncommon(at least 1 in 1,000 patients): ringing or buzzing in the ears.
Rare(at least 1 in 10,000 patients): hearing difficulty.
Ocular:
Uncommon(at least 1 in 1,000 patients): vision changes.
Rare(at least 1 in 10,000 patients): abnormal or blurred vision.
Blood:
Very rare(less than 1 in 10,000 patients): prolonged bleeding time, decreased white blood cells (may manifest as frequent infections with fever, chills, or sore throat), decreased red blood cells (may manifest as difficulty breathing and skin pallor).
Renal:
Based on experience with NSAIDs in general, cases of interstitial nephritis (kidney disorder), nephrotic syndrome (disorder characterized by protein in the urine and body swelling), and renal failure (sudden loss of kidney function) cannot be excluded.
Hepatic:
Medications like Ibuprofeno ABDrug may be associated, in rare cases, with liver damage.
Other rare adverse effects(at least 1 in 10,000 patients) are: hepatitis (liver inflammation), liver function abnormalities, and jaundice (yellowing of the skin and eyes).
Frequency not known: liver failure (severe liver deterioration).
General:
Worsening of inflammation during infectious processes.
To date, no severe allergic reactions have been reported with Ibuprofeno ABDrug, although they cannot be ruled out. The manifestations of this type of reaction could be fever, skin rash, abdominal pain, severe and persistent headache, nausea, vomiting, facial swelling, tongue and throat swelling, difficulty breathing, asthma, palpitations, hypotension, or shock.
If any of the following adverse effects appear, discontinue treatment and seek medical attention immediately:
Adverse Effect Reporting
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep out of the reach and sight of children.
Store at a temperature below 30°C.
Do not use Ibuprofeno ABDrug after the expiration date shown on the packaging after "CAD". The expiration date is the last day of the month indicated.
Medications should not be thrown away through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Ibuprofeno ABDrug
Appearance of the Product and Packaging Content
Oval, biconvex, and white film-coated tablets.
Available in packaging with
40 tablets.
Marketing Authorization Holder and Manufacturer
Holder:
MABO-FARMA, S.A.
Vía de los Poblados, 3, Edificio 6
28033 Madrid,
Spain.
Manufacturer:
Farmalider, S.A.
C/Aragoneses, nº 2.
28108-Alcobendas (Madrid)
Spain
or
FROSST IBERICA, S.A.
Via Complutense, 140
28805 Alcalá de Henares (Madrid), Spain
or
PHARMALOOP, S.L.
c/ Bolivia, 15 – Polígono Industrial Azque
28806 Alcalá de Henares (Madrid), Spain
or
TOLL MANUFACTURING SERVICES S.L.
C/Aragoneses, 2
28108 Alcobendas (Madrid)
Spain
Date of the Last Revision of this Leaflet: November 2024.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of IBUPROFEN ABDRUG 600 mg FILM-COATED TABLETS in October, 2025 is around 1.97 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for IBUPROFEN ABDRUG 600 mg FILM-COATED TABLETS – subject to medical assessment and local rules.